Trial Profile
Phase 1 Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and in Bancoumana, Mali
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Agatolimod (Primary) ; Aluminium hydroxide (Primary) ; Malaria vaccine (Primary) ; Hepatitis B vaccine recombinant
- Indications Falciparum malaria; Hepatitis B
- Focus Adverse reactions; Pharmacodynamics